A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...